SCHEMBL9836815

SCHEMBL9836815

CCOC(=O)c1cnc2cc(Cl)sc2c1O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
KDM4E B2RXH2 3/20 0.43
MAPT P10636 3/20 0.43
GAA P10253 1/20 0.43
MAPK1 P28482 3/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPK10 P53779 1/20 0.42
PKM P14618 1/20 0.41
DYRK1A Q13627 4/20 0.41
HPGD P15428 2/20 0.40
RECQL P46063 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10997351 0.88 KMT2A (0.46) KMT2AMEN1KDM4EMAPTGAA
SCHEMBL9837120 0.86 KDM4E (0.44) KMT2AMEN1KDM4EMAPTGAA
SCHEMBL4896376 0.84 MAPK1 (0.43) KMT2AMEN1KDM4EMAPTGAA
SCHEMBL6491371 0.84 MAP3K8 (0.50) KMT2AMEN1KDM4EMAPTGAA
SCHEMBL11578876 0.81 MAPT (0.49) KMT2AMEN1KDM4EMAPTGAA
SCHEMBL9837084 0.79 ALDH1A1 (0.56) KMT2AMEN1KDM4EMAPTGAA
SCHEMBL483292 0.76 ALDH1A1 (0.47) KMT2AMEN1KDM4EMAPTGAA
SCHEMBL4902910 0.75 KMT2A (0.44) KMT2AMEN1KDM4EMAPTGAA
SCHEMBL2799946 0.75 KMT2A (0.45) KMT2AMEN1KDM4EMAPTGAA
SCHEMBL29810251 0.75 KMT2A (0.45) KMT2AMEN1KDM4EMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0046990-A2 2-Halogeno-4-alkyl-4,7-dihydro-7-oxo-thieno(3,2-b)-pyridine-6-carboxylic acids, salts thereof at the carboxyl group, pharmaceutical use thereof, and intermediates thereof KANEBO, LTD. (JP) 1982-03-10 EP claimed
EP-0269295-B1 THERAPEUTIC AGENTS The Boots Company PLC (GB) 1991-06-26 EP disclosed
US-4877793-A CARDIOVASCULAR DISORDERS THE BOOTS COMPANY, PLC (GB) 1989-10-31 US disclosed
EP-0046990-A2 2-Halogeno-4-alkyl-4,7-dihydro-7-oxo-thieno(3,2-b)-pyridine-6-carboxylic acids, salts thereof at the carboxyl group, pharmaceutical use thereof, and intermediates thereof KANEBO, LTD. (JP) 1982-03-10 EP disclosed